Matches in SemOpenAlex for { <https://semopenalex.org/work/W2168447335> ?p ?o ?g. }
- W2168447335 endingPage "528" @default.
- W2168447335 startingPage "519" @default.
- W2168447335 abstract "Y-700 (1-[3-Cyano-4-(2,2-dimethylpropoxy)phenyl]-1<i>H</i>-pyrazole-4-carboxylic acid) is a newly synthesized inhibitor of xanthine oxidoreductase (XOR). Steady-state kinetics with the bovine milk enzyme indicated a mixed type inhibition with <i>K</i><sub>i</sub> and <i>K</i><sub>i</sub> ′ values of 0.6 and 3.2 nM, respectively. Titration experiments showed that Y-700 bound tightly both to the active sulfo-form and to the inactive desulfo-form of the enzyme with <i>K</i><sub>d</sub> values of 0.9 and 2.8 nM, respectively. X-ray crystallographic analysis of the enzyme-inhibitor complex revealed that Y-700 closely interacts with the channel leading to the molybdenum-pterin active site but does not directly coordinate to the molybdenum ion. In oxonate-treated rats, orally administered Y-700 (1–10 mg/kg) dose dependently lowered plasma urate levels. At a dose of 10 mg/kg, the hypouricemic action of Y-700 was more potent and of longer duration than that of 4-hydroxypyrazolo(3,4-<i>d</i>)pyrimidine, whereas its action was approximately equivalent to that of 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylic acid, a nonpurine inhibitor of XOR. In normal rats, orally administered Y-700 (0.3–3 mg/kg) dose dependently reduced the urinary excretion of urate and allantoin, accompanied by an increase in the excretion of hypoxanthine and xanthine. Y-700 (1 mg/kg) was absorbed rapidly by the oral route with high bioavailability (84.1%). Y-700 was hardly excreted via the kidneys but was mainly cleared via the liver. These results suggest that Y-700 will be a promising candidate for the treatment of hyperuricemia and other diseases in which XOR may be involved." @default.
- W2168447335 created "2016-06-24" @default.
- W2168447335 creator A5009567046 @default.
- W2168447335 creator A5011237103 @default.
- W2168447335 creator A5018240999 @default.
- W2168447335 creator A5026595203 @default.
- W2168447335 creator A5043689424 @default.
- W2168447335 creator A5056974084 @default.
- W2168447335 creator A5081814794 @default.
- W2168447335 creator A5084130320 @default.
- W2168447335 date "2004-06-09" @default.
- W2168447335 modified "2023-10-03" @default.
- W2168447335 title "Y-700 [1-[3-Cyano-4-(2,2-dimethylpropoxy)phenyl]-1<i>H</i>-pyrazole-4-carboxylic Acid]: A Potent Xanthine Oxidoreductase Inhibitor with Hepatic Excretion" @default.
- W2168447335 cites W1489147212 @default.
- W2168447335 cites W1519300281 @default.
- W2168447335 cites W1539796472 @default.
- W2168447335 cites W1581259330 @default.
- W2168447335 cites W1584018467 @default.
- W2168447335 cites W1828830410 @default.
- W2168447335 cites W1866713406 @default.
- W2168447335 cites W1969856573 @default.
- W2168447335 cites W1970079034 @default.
- W2168447335 cites W1970540527 @default.
- W2168447335 cites W1993419780 @default.
- W2168447335 cites W2005685981 @default.
- W2168447335 cites W2013083986 @default.
- W2168447335 cites W2016010450 @default.
- W2168447335 cites W2027365101 @default.
- W2168447335 cites W2036088572 @default.
- W2168447335 cites W2047276432 @default.
- W2168447335 cites W2073496185 @default.
- W2168447335 cites W2080528351 @default.
- W2168447335 cites W2086544233 @default.
- W2168447335 cites W2097744068 @default.
- W2168447335 cites W2107419879 @default.
- W2168447335 cites W2115821683 @default.
- W2168447335 cites W2117211161 @default.
- W2168447335 cites W2132425318 @default.
- W2168447335 cites W2136310944 @default.
- W2168447335 cites W2139495786 @default.
- W2168447335 cites W2165447689 @default.
- W2168447335 cites W4245399940 @default.
- W2168447335 cites W68869269 @default.
- W2168447335 doi "https://doi.org/10.1124/jpet.104.070433" @default.
- W2168447335 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15190124" @default.
- W2168447335 hasPublicationYear "2004" @default.
- W2168447335 type Work @default.
- W2168447335 sameAs 2168447335 @default.
- W2168447335 citedByCount "105" @default.
- W2168447335 countsByYear W21684473352012 @default.
- W2168447335 countsByYear W21684473352013 @default.
- W2168447335 countsByYear W21684473352014 @default.
- W2168447335 countsByYear W21684473352015 @default.
- W2168447335 countsByYear W21684473352016 @default.
- W2168447335 countsByYear W21684473352017 @default.
- W2168447335 countsByYear W21684473352018 @default.
- W2168447335 countsByYear W21684473352019 @default.
- W2168447335 countsByYear W21684473352020 @default.
- W2168447335 countsByYear W21684473352021 @default.
- W2168447335 countsByYear W21684473352022 @default.
- W2168447335 countsByYear W21684473352023 @default.
- W2168447335 crossrefType "journal-article" @default.
- W2168447335 hasAuthorship W2168447335A5009567046 @default.
- W2168447335 hasAuthorship W2168447335A5011237103 @default.
- W2168447335 hasAuthorship W2168447335A5018240999 @default.
- W2168447335 hasAuthorship W2168447335A5026595203 @default.
- W2168447335 hasAuthorship W2168447335A5043689424 @default.
- W2168447335 hasAuthorship W2168447335A5056974084 @default.
- W2168447335 hasAuthorship W2168447335A5081814794 @default.
- W2168447335 hasAuthorship W2168447335A5084130320 @default.
- W2168447335 hasConcept C10146269 @default.
- W2168447335 hasConcept C151400659 @default.
- W2168447335 hasConcept C181199279 @default.
- W2168447335 hasConcept C185592680 @default.
- W2168447335 hasConcept C197957613 @default.
- W2168447335 hasConcept C2776055822 @default.
- W2168447335 hasConcept C2778102346 @default.
- W2168447335 hasConcept C2779470414 @default.
- W2168447335 hasConcept C2779881121 @default.
- W2168447335 hasConcept C2781116151 @default.
- W2168447335 hasConcept C55493867 @default.
- W2168447335 hasConcept C71240020 @default.
- W2168447335 hasConceptScore W2168447335C10146269 @default.
- W2168447335 hasConceptScore W2168447335C151400659 @default.
- W2168447335 hasConceptScore W2168447335C181199279 @default.
- W2168447335 hasConceptScore W2168447335C185592680 @default.
- W2168447335 hasConceptScore W2168447335C197957613 @default.
- W2168447335 hasConceptScore W2168447335C2776055822 @default.
- W2168447335 hasConceptScore W2168447335C2778102346 @default.
- W2168447335 hasConceptScore W2168447335C2779470414 @default.
- W2168447335 hasConceptScore W2168447335C2779881121 @default.
- W2168447335 hasConceptScore W2168447335C2781116151 @default.
- W2168447335 hasConceptScore W2168447335C55493867 @default.
- W2168447335 hasConceptScore W2168447335C71240020 @default.
- W2168447335 hasIssue "2" @default.
- W2168447335 hasLocation W21684473351 @default.
- W2168447335 hasLocation W21684473352 @default.
- W2168447335 hasOpenAccess W2168447335 @default.